medigraphic.com
SPANISH

Medicina Crítica

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • Policies
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2011, Number 2

<< Back Next >>

Med Crit 2011; 25 (2)

Carbon dioxide delta to evaluate tisular perfusion as mortality predictor in septic shock

Hernández LA, López PHR, Etulain GJE, Olvera GC, Aguirre SJ, Franco GJ
Full text How to cite this article

Language: Spanish
References: 10
Page: 66-70
PDF size: 326.96 Kb.


Key words:

CO2 delta, septic shock, tisular perfusion.

ABSTRACT

Introduction: ΔCO2 has been used as tissular perfusion parameter in the postoperative period of cardiovascular surgery.
Objectives: To evaluate ΔCO2 as tissue perfusion parameter in patients with septic shock as well as it’s utility in predicting mortality.
Methods: Prospective observational study from March 2009 to March 2010.
Results: 46 patients with septic shock were included and divided in one of two groups: high ΔCO2 (n = 11) and low ΔCO2 (n = 35). Demographics as well as reanimation parameters and optimization of goals in both groups were similar. Mortality was higher in high ΔCO2 group vs low ΔCO2 group: 34% vs 2.8% respectively.
Conclusion: ΔCO2 higher than 6 mmHg is an adequate parameter for the evaluation of tissular perfusion in septic shock patients. ΔCO2 higher than 6 mmHg and that does not lowers after reanimation predicts a bad prognosis in septic patients.


REFERENCES

  1. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea BJ, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32:858-873.

  2. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M. Early goal directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-1377.

  3. Mecher CE, Rackow EC, Astiz ME, Weil MH. Venous hypercarbia associated with severe sepsis and systemic hypoperfusion. Crit Care Med 1990;18:585-589.

  4. Bakker J, Vincent JL, Gris P, Leon M, Coffernils M, Kahn RJ. Venoarterial carbon dioxide gradient in human septic shock. Chest 1992;101:509-515.

  5. Rackow EC, Astiz ME, Mecher CE, Weil MH. Increased venous arterial carbon dioxide tension difference during severe sepsis in rats. Crit Care Med 1994;22:121-125.

  6. Ariza M, Gothard JWW, MacNaughton P. Blood lactate and mixed venous arterial PCO2 gradient as indices of poor peripheral perfusion following cardiopulmonary bypass surgery. Intensive Care Med 1991;17:320-324.

  7. Cavaliere F, Martinelli L, Guarneri S, Varano C, Rossi M, Schiavello R. Arterial-venous PCO2 gradient in early postoperative hours following myocardial revascularization. J Cardiovasc Surg (Torino) 1996;37(5):499-503.

  8. Cuschieri J, Rivers E, Michael W. Central venous-arterial carbon dioxide difference as an indicator of cardiac index. Donnino Intensive Care Med 2005;31:818-822.

  9. Neviere R, Chagnon JL, Teboul JL, Vallet B, Wattel F. Small intestine intramucosal PCO2 and microvascular blood flow during hypoxic and ischemic hypoxia. Crit Care Med 2002;30:379-384.

  10. Johnson BA, Weil MH. Redefining ischemia due to circulatory failure as dual defects of oxygen deficits and of carbon dioxide excesses. Crit Care Med 1991;19:1432-438.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Crit. 2011;25